Pharmacogenetic Risk Scores for Perindopril Clinical and Cost Effectiveness in Stable Coronary Artery Disease: When Are We Ready to Implement?

ABSTRACT:

SUBMITTER: Luzum JA 

PROVIDER: S-EPMC4943290 | biostudies-literature | 2016 Mar

REPOSITORIES: biostudies-literature